Literature DB >> 30065113

Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.

Lei Deng1, Timothy Z Chang2, Ye Wang1, Song Li2, Shelly Wang3, Shingo Matsuyama1, Guoying Yu4, Richard W Compans3, Jian-Dong Li1, Mark R Prausnitz2, Julie A Champion2, Bao-Zhong Wang5.   

Abstract

Influenza is a persistent threat to public health. Here we report that double-layered peptide nanoparticles induced robust specific immunity and protected mice against heterosubtypic influenza A virus challenges. We fabricated the nanoparticles by desolvating a composite peptide of tandem copies of nucleoprotein epitopes into nanoparticles as cores and cross-linking another composite peptide of four tandem copies of influenza matrix protein 2 ectodomain epitopes to the core surfaces as a coating. Delivering the nanoparticles via dissolvable microneedle patch-based skin vaccination further enhanced the induced immunity. These peptide-only, layered nanoparticles demonstrated a strong antigen depot effect and migrated into spleens and draining (inguinal) lymph nodes for an extended period compared with soluble antigens. This increased antigen-presentation time correlated with the stronger immune responses in the nanoparticle-immunized group. The protection conferred by nanoparticle immunization was transferable by passive immune serum transfusion and depended partially on a functional IgG receptor FcγRIV. Using a conditional cell depletion, we found that CD8+ T cells were involved in the protection. The immunological potency and stability of the layered peptide nanoparticles indicate applications for other peptide-based vaccines and peptide drug delivery.

Entities:  

Keywords:  epitope; influenza A virus; microneedle; nanoparticle; universal influenza vaccine

Mesh:

Substances:

Year:  2018        PMID: 30065113      PMCID: PMC6099848          DOI: 10.1073/pnas.1805713115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

Review 1.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

2.  Natural and long-lasting cellular immune responses against influenza in the M2e-immune host.

Authors:  M Schotsaert; T Ysenbaert; K Neyt; L I Ibañez; P Bogaert; B Schepens; B N Lambrecht; W Fiers; X Saelens
Journal:  Mucosal Immunol       Date:  2012-07-18       Impact factor: 7.313

3.  Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.

Authors:  Marc Pearton; Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim; Fu-Shi Quan; Alexander Anstey; Matthew Ivory; Mark R Prausnitz; Richard W Compans; James C Birchall
Journal:  Vaccine       Date:  2010-06-08       Impact factor: 3.641

4.  Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.

Authors:  Yang Pan; Quanyi Wang; Peng Yang; Li Zhang; Shuangsheng Wu; Yi Zhang; Ying Sun; Wei Duan; Chunna Ma; Man Zhang; Xingxing Zhang; C Raina MacIntyre
Journal:  Vaccine       Date:  2017-11-08       Impact factor: 3.641

5.  A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.

Authors:  José Herrera-Rodriguez; Tjarko Meijerhof; Hubert G Niesters; Grete Stjernholm; Arnt-Ove Hovden; Birger Sørensen; Mats Ökvist; Maja A Sommerfelt; Anke Huckriede
Journal:  Virology       Date:  2017-12-07       Impact factor: 3.616

6.  pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.

Authors:  John T Wilson; Salka Keller; Matthew J Manganiello; Connie Cheng; Chen-Chang Lee; Chinonso Opara; Anthony Convertine; Patrick S Stayton
Journal:  ACS Nano       Date:  2013-04-30       Impact factor: 15.881

7.  Protein nanoparticles for intracellular delivery of therapeutic enzymes.

Authors:  Lina Herrera Estrada; Stanley Chu; Julie A Champion
Journal:  J Pharm Sci       Date:  2014-04-16       Impact factor: 3.534

8.  Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.

Authors:  Richard D Antrobus; Tamara K Berthoud; Caitlin E Mullarkey; Katja Hoschler; Lynda Coughlan; Maria Zambon; Adrian V S Hill; Sarah C Gilbert
Journal:  Mol Ther       Date:  2013-07-08       Impact factor: 11.454

9.  Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.

Authors:  Nicole L Kallewaard; Davide Corti; Patrick J Collins; Ursula Neu; Josephine M McAuliffe; Ebony Benjamin; Leslie Wachter-Rosati; Frances J Palmer-Hill; Andy Q Yuan; Philip A Walker; Matthias K Vorlaender; Siro Bianchi; Barbara Guarino; Anna De Marco; Fabrizia Vanzetta; Gloria Agatic; Mathilde Foglierini; Debora Pinna; Blanca Fernandez-Rodriguez; Alexander Fruehwirth; Chiara Silacci; Roksana W Ogrodowicz; Stephen R Martin; Federica Sallusto; JoAnn A Suzich; Antonio Lanzavecchia; Qing Zhu; Steven J Gamblin; John J Skehel
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

10.  Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.

Authors:  Li Wang; Annie Hess; Timothy Z Chang; Ying-Chun Wang; Julie A Champion; Richard W Compans; Bao-Zhong Wang
Journal:  Nanomedicine       Date:  2013-08-27       Impact factor: 5.307

View more
  23 in total

Review 1.  Microneedle-Mediated Vaccine Delivery to the Oral Mucosa.

Authors:  Rachel L Creighton; Kim A Woodrow
Journal:  Adv Healthc Mater       Date:  2018-12-10       Impact factor: 9.933

2.  Double-Layered M2e-NA Protein Nanoparticle Immunization Induces Broad Cross-Protection against Different Influenza Viruses in Mice.

Authors:  Ye Wang; Lei Deng; Gilbert X Gonzalez; Latika Luthra; Chunhong Dong; Yao Ma; Jun Zou; Sang-Moo Kang; Bao-Zhong Wang
Journal:  Adv Healthc Mater       Date:  2019-12-15       Impact factor: 9.933

3.  Influenza NP core and HA or M2e shell double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.

Authors:  Yao Ma; Ye Wang; Chunhong Dong; Gilbert X Gonzalez; Yufeng Song; Wandi Zhu; Joo Kim; Lai Wei; Bao-Zhong Wang
Journal:  Nanomedicine       Date:  2021-11-04       Impact factor: 5.307

4.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

Review 5.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

6.  Pharmacokinetic tuning of protein-antigen fusions enhances the immunogenicity of T-cell vaccines.

Authors:  Naveen K Mehta; Roma V Pradhan; Ava P Soleimany; Kelly D Moynihan; Adrienne M Rothschilds; Noor Momin; Kavya Rakhra; Jordi Mata-Fink; Sangeeta N Bhatia; K Dane Wittrup; Darrell J Irvine
Journal:  Nat Biomed Eng       Date:  2020-06-01       Impact factor: 25.671

Review 7.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

Review 8.  Universal influenza vaccines: from viruses to nanoparticles.

Authors:  Ye Wang; Lei Deng; Sang-Moo Kang; Bao-Zhong Wang
Journal:  Expert Rev Vaccines       Date:  2018-11-02       Impact factor: 5.217

9.  Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.

Authors:  Peiyang Ding; Qianyue Jin; Xinxin Chen; Suzhen Yang; Junqing Guo; Guangxu Xing; Ruiguang Deng; Aiping Wang; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2019-09-16

10.  Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses.

Authors:  Ye Wang; Song Li; Chunhong Dong; Yao Ma; Yufeng Song; Wandi Zhu; Joo Kim; Lei Deng; Timothy L Denning; Sang-Moo Kang; Mark R Prausnitz; Bao-Zhong Wang
Journal:  ACS Appl Bio Mater       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.